Clinical Trials List
Protocol NumberNSC-98-2314-B-075-034
Not yet recruiting
2009-08-01 - 2011-07-31
Phase III
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- 王世楨 Division of Nuclear Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
0 participants
